ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 111 filers reported holding ALBIREO PHARMA INC in Q1 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $42,279,706 | -3.3% | 1,956,488 | -13.4% | 0.12% | -8.6% |
Q3 2022 | $43,717,000 | -2.4% | 2,258,124 | +0.1% | 0.13% | +4.9% |
Q2 2022 | $44,787,000 | -36.3% | 2,255,124 | -4.4% | 0.12% | -23.3% |
Q1 2022 | $70,358,000 | +28.1% | 2,358,624 | 0.0% | 0.16% | +55.9% |
Q4 2021 | $54,932,000 | -25.4% | 2,358,624 | -0.1% | 0.10% | -27.1% |
Q3 2021 | $73,648,000 | -11.3% | 2,360,524 | -0.0% | 0.14% | -9.7% |
Q2 2021 | $83,062,000 | -0.2% | 2,361,058 | 0.0% | 0.16% | -3.7% |
Q1 2021 | $83,227,000 | -9.3% | 2,361,058 | -3.5% | 0.16% | -14.4% |
Q4 2020 | $91,787,000 | +13.9% | 2,447,000 | +1.3% | 0.19% | -0.5% |
Q3 2020 | $80,585,000 | +59.0% | 2,414,900 | +26.2% | 0.19% | +51.2% |
Q2 2020 | $50,680,000 | +61.8% | 1,913,190 | 0.0% | 0.12% | +35.9% |
Q1 2020 | $31,319,000 | -14.3% | 1,913,190 | +33.1% | 0.09% | +13.6% |
Q4 2019 | $36,529,000 | +27.1% | 1,437,000 | 0.0% | 0.08% | +14.1% |
Q3 2019 | $28,740,000 | -38.0% | 1,437,000 | 0.0% | 0.07% | -36.6% |
Q2 2019 | $46,329,000 | +99.9% | 1,437,000 | +99.7% | 0.11% | +96.5% |
Q1 2019 | $23,178,000 | +61.2% | 719,595 | +22.8% | 0.06% | +46.2% |
Q4 2018 | $14,378,000 | -25.6% | 586,146 | -0.0% | 0.04% | -13.3% |
Q3 2018 | $19,321,000 | -7.1% | 586,207 | +0.0% | 0.04% | -26.2% |
Q2 2018 | $20,808,000 | +106.1% | 586,146 | +89.1% | 0.06% | +110.3% |
Q1 2018 | $10,094,000 | – | 309,925 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 514,082 | $11,973,000 | 7.17% |
Privium Fund Management B.V. | 379,117 | $8,959,000 | 1.78% |
Birchview Capital, LP | 113,000 | $2,632,000 | 1.70% |
Sio Capital Management, LLC | 213,913 | $4,982,000 | 1.50% |
Perceptive Advisors | 4,720,278 | $109,936,000 | 0.85% |
Chicago Capital, LLC | 849,239 | $19,779,000 | 0.74% |
APOGEM CAPITAL LLC | 38,601 | $899,000 | 0.59% |
Samsara BioCapital, LLC | 100,000 | $2,329,000 | 0.45% |
Artal Group S.A. | 600,000 | $13,974,000 | 0.38% |
RICE HALL JAMES & ASSOCIATES, LLC | 458,011 | $10,667,000 | 0.38% |